- Led briefing and presented oral argument in the D.C. Circuit in a litigation that resulted in the dismissal of a challenge to a shipping client’s eligibility to participate in the “Maritime Security Program” administered by the Maritime Administration and the Department of Defense. See Matson Navigation Co. v. U.S. Dep’t of Transp., 895 F.3d 799 (D.C. Cir. 2018).
- Led merits briefing in several matters in the U.S. Supreme Court. Co-authored brief and served as second-chair in Supreme Court litigation concerning the test for whether an artistic design feature can qualify for a copyright. Mr. Burgess represented the copyright owner, which designed original artwork appearing on clothing. The Supreme Court held by a vote of 6-2 that the designs were copyright-eligible. Star Athletica, LLC v. Varsity Brands, Inc., 137 S. Ct. 1002 (2017).
- Co-authored brief in D.C. Circuit on behalf of a pharmaceutical company defending approval of its new drug application against a competitor’s exclusivity challenge. The D.C. Circuit upheld FDA’s approval of our client’s application in a decision that set an important precedent on the scope of 3-year exclusivities for new clinical investigations. Otsuka Pharm. Co. v. Price, 869 F.3d 987 (D.C. Cir. 2017).
- Served as counsel of record to U.S. Chamber of Commerce in briefs in the Third Circuit and the Ninth Circuit concerning the pleading standards applicable to ERISA claims alleging fiduciary breach.
- Co-authored briefs in the Second Circuit on behalf of a major banking client in a putative class-action alleging violations of the Racketeering Influenced and Corrupt Organizations Act based on the rates charged for lender-placed insurance. Successfully obtained interlocutory review and reversal of adverse judgment resulting in an order to dismiss all claims. Rothstein v. Balboa Insurance Company, 794 F.3d 256 (2d Cir. 2015).
- Co-authored motion to dismiss briefing in litigation in the Southern District of New York defending a leading test-preparation company against Sherman Act and RICO claims brought by a competitor. Court dismissed antitrust and RICO claims with prejudice.
- Defending a leading pharmaceutical manufacturer in putative class actions challenging patent litigation settlements on antitrust grounds, initiated after the Supreme Court’s decision in FTC v. Actavis, 133 S. Ct. 2223 (2013). Co-authored motions to dismiss briefs in complex multidistrict litigation resulting in dismissal of several claims and complete dismissal of claims against the parent corporation.
- Co-authored briefs on behalf of a leading pharmaceutical manufacturer and several other intervenors in a suit against FDA seeking to stop the launch of generic versions of the drug Abilify.® Successfully opposed a preliminary injunction and then obtained summary judgment.
- Co-authored several briefs in opposition to petition for certiorari in the Supreme Court, including a brief in a First Amendment challenge to a transit authority’s advertising policy, a brief concerning the rules for claim construction in patent litigation, and a brief in a Sixth Amendment sentencing case in opposition to the Michigan Attorney General.
- Presented oral argument and successfully persuaded the Fourth Circuit to vacate in a pro bono matter challenging a county’s anti-panhandling ordinance as inconsistent with the First Amendment. Reynolds v. Middleton, 779 F.3d 222 (4th Cir. 2015).
Areas of Practice
Experience
In The News
MELDUNGEN
ACTUALITÉS
相关新闻
Credentials
Education
J.D., 2009
New York University
(summa cum laude)
New York University
(summa cum laude)
A.B., 2005
Dartmouth College
(summa cum laude)
Dartmouth College
(summa cum laude)
Clerkships
2012-2013 U.S. Supreme Court, Honorable Sonia M. Sotomayor
2010-2011 U.S. Court of Appeals for the District of Columbia Circuit, Honorable David S. Tatel
2009-2010 U.S. Court of Appeals for the Second Circuit, Honorable Guido Calabresi
Admissions
Bar
Courts
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Search Other Lawyers